{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-018338","form_type":"8-K","ticker":"PRKR","cik":"0000914139","company_name":"PARKERVISION INC","filed_at":"2023-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.782432+00:00","generated_at":"2026-06-13T17:28:30.560399+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"ParkerVision appoints Lewis Titterton as Class II director","bullets":["Effective June 22, 2023, Titterton fills a board vacancy; he previously served from Sept 2018 to Apr 2019.","Titterton is lead independent director at Anixa Biosciences (ANIX) and chaired NYMED's board.","CEO Jeffery Parker praised Titterton's biotech background as relevant to ParkerVision's licensing strategy.","Company entered a standard indemnification agreement with Titterton."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-018338","json":"https://secwatch.observer/filing/0001437749-23-018338.json","markdown":"https://secwatch.observer/filing/0001437749-23-018338.md","text":"https://secwatch.observer/filing/0001437749-23-018338.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/914139/000143774923018338/0001437749-23-018338-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/914139/000143774923018338/prkr20230624_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T17:28:30.560399+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"67c1445da1","claim":"Lewis H. Titterton was appointed as Class II director at PARKERVISION INC.","evidence_excerpt":"Effective June 22, 2023, the Board of Directors of the Company appointed Lewis H. Titterton to fill a Class II director vacancy.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/914139/000143774923018338/0001437749-23-018338-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}